Cerebral Energy Metabolism in Geriatric Bipolar Depression
老年双相抑郁症的大脑能量代谢
基本信息
- 批准号:8424297
- 负责人:
- 金额:$ 17.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:AftercareAgeAgingAging-Related ProcessAnimalsAnteriorAreaBeliefBiochemicalBiochemical MarkersBiometryBipolar DepressionBipolar DisorderBrainBrain imagingBrain-Derived Neurotrophic FactorCerebrumChronicClinicalClinical PharmacologyClinical SkillsClinical TrialsCollaborationsComplexCross-Sectional StudiesDataDefectDementiaDevelopmentDiagnosisDiagnosticDiagnostic ProcedureElderlyEnergy MetabolismEvaluationFunctional disorderFutureGenesGlutamatesGlutamineGoalsHealthHealth ServicesHealth systemHealthcareHospitalsImageImaging TechniquesImaging technologyIndividualInstitutesInterviewLaboratoriesMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMeasuresMentorsMontgomery and Asberg depression rating scaleMoodsMorphologic artifactsN-acetylaspartateNeuropsychological TestsOccipital lobePathologyPatientsPerformancePharmaceutical PreparationsPhaseProtonsPsychotic Mood DisordersPublic HealthRecording of previous eventsReportingResearchResearch PersonnelScanningSemanticsSeveritiesSiteSorting - Cell MovementStructureSymptomsTechniquesTestingTherapeuticTherapeutic InterventionTrainingWisconsinburnoutcareercingulate cortexdepressive symptomsdisabilityearly onseteffective therapyexecutive functionfunctional declineinclusion criteriainformation processinglamotriginemeetingsmitochondrial dysfunctionmortalityneuropsychologicalolder patientopen labelprocessing speedprogramsresponseresponsible research conducttreatment responseyoung adult
项目摘要
DESCRIPTION (provided by applicant): Dr. Forester aims to become an independent investigator in the field of geriatric bipolar disorder using magnetic resonance spectroscopy (MRS) to study biochemical markers of treatment response. Long-term career goals include collaboration with other centers employing MR imaging (MRI) technologies to study geriatric bipolar disorder with a focus on developing safe and effective therapeutic interventions. Dr. Forester will be mentored at McLean Hospital by Dr. Bruce Cohen, past President of McLean Hospital and current Director of the Frazier Institute, an interdisciplinary consortium studying bipolar disorder using clinical pharmacology, MRS, functional MR and laboratory techniques, and co-mentored by Dr. Perry Renshaw, of the McLean Hospital Brain Imaging Center. Dr. Forester will enhance his clinical skills with formal training in MRI techniques and applications, biostatistics and the responsible conduct of research. The proposed research plan will employ MRS to study measures of brain energy metabolism in 35 older adults with bipolar depression and 25 healthy age-matched controls. Subjects meeting inclusion criteria will be clinically characterized at baseline with a structured psychiatric interview and neuropsychological testing and will undergo proton (1H) MRS study at 4 Tesla. Subjects with bipolar depression will then receive open label treatment with lamotrigine as monotherapy or adjunctive therapy for eight weeks. At the end of 8 weeks, both groups will undergo a second 1H MRS scan at 4 Tesla. Group differences in the brain energy metabolites, glutamate, glutamine, N-acetyl aspartate and lactate, among control subjects and subjects with bipolar disorder will be analyzed at baseline and after treatment.
描述(由申请人提供):Forester博士的目的是使用磁共振光谱(MRS)研究老年躁郁症领域的独立研究者,以研究治疗反应的生化标志物。长期职业目标包括与其他采用MR成像(MRI)技术研究老年躁郁症的中心合作,重点是开发安全有效的治疗干预措施。 Forester博士将在麦克莱恩医院(McLean Hospital)由McLean Hospital的前任主席,现任Frazier Institute的主任Bruce Cohen博士进行指导,Frazier Institute是一个跨学科的财团,使用临床药理学,MRS,功能性MR和实验室技术研究双极疾病,并由McLean Hospital Hospital Hospital Brine Image Center进行了Perry Renshaw博士。 Forester博士将通过MRI技术和应用,生物统计学和负责任的研究进行正式培训来提高他的临床技能。拟议的研究计划将利用MRS研究35名患有躁郁症抑郁症和25个健康年龄匹配的对照的老年人的脑能量代谢的措施。符合纳入标准的受试者将在基线上通过结构化的精神访谈和神经心理学测试在临床上进行临床表征,并将在4 Tesla进行质子(1H)MRS研究。然后,患有躁郁症抑郁症的受试者将接受八个星期的单一疗法或辅助治疗的开放式标签治疗。在8周结束时,两组将在4特斯拉进行第二次1小时扫描MRS扫描。在基线和治疗后,将分析脑能量代谢产物,谷氨酸,谷氨酰胺,谷氨酸天冬氨酸和乳酸的群体差异,对照组和患有双相情感障碍的受试者的群体差异。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Clinical Characteristics of Patients with Late Life Bipolar Disorder in the Community: Data from the NNDC Registry.
社区晚年双相情感障碍患者的临床特征:来自 NNDC 登记处的数据。
- DOI:10.1016/j.jagp.2015.01.001
- 发表时间:2015
- 期刊:
- 影响因子:0
- 作者:Forester,BrentP;Ajilore,Olu;Spino,Cathie;Lehmann,SusanW
- 通讯作者:Lehmann,SusanW
Antidepressant effects of open label treatment with coenzyme Q10 in geriatric bipolar depression.
- DOI:10.1097/jcp.0000000000000326
- 发表时间:2015-06
- 期刊:
- 影响因子:2.9
- 作者:Forester BP;Harper DG;Georgakas J;Ravichandran C;Madurai N;Cohen BM
- 通讯作者:Cohen BM
Spiritual struggle and affective symptoms among geriatric mood disordered patients.
- DOI:10.1002/gps.4052
- 发表时间:2014-06
- 期刊:
- 影响因子:4
- 作者:Rosmarin, David H.;Malloy, Mary C.;Forester, Brent P.
- 通讯作者:Forester, Brent P.
Interest in spiritually integrated psychotherapy among acute psychiatric patients.
对急性精神病患者的精神整合心理治疗感兴趣。
- DOI:10.1037/ccp0000046
- 发表时间:2015
- 期刊:
- 影响因子:5.9
- 作者:Rosmarin,DavidH;Forester,BrentP;Shassian,DanielM;Webb,ChristianA;Björgvinsson,Thröstur
- 通讯作者:Björgvinsson,Thröstur
Lamotrigine Therapy and Biomarkers of Cerebral Energy Metabolism in Older Age Bipolar Depression.
拉莫三嗪治疗和老年双相抑郁症脑能量代谢的生物标志物。
- DOI:10.1016/j.jagp.2019.02.017
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Mellen,EmilyJ;Harper,DavidG;Ravichandran,Caitlin;Jensen,Eric;Silveri,Marisa;Forester,BrentP
- 通讯作者:Forester,BrentP
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brent Peter Forester其他文献
Brent Peter Forester的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brent Peter Forester', 18)}}的其他基金
A Randomized Controlled Trial of Electroconvulsive Therapy plus Usual Care versus Simulated-ECT plus Usual Care for the Acute Management of Severe Agitation in Alzheimer's Dementia (ECT-AD)
电惊厥疗法加常规护理与模拟 ECT 加常规护理对阿尔茨海默氏痴呆症严重激越急性管理 (ECT-AD) 的随机对照试验
- 批准号:
10411985 - 财政年份:2018
- 资助金额:
$ 17.94万 - 项目类别:
A Randomized Controlled Trial of Electroconvulsive Therapy plus Usual Care versus Simulated-ECT plus Usual Care for the Acute Management of Severe Agitation in Alzheimer's Dementia (ECT-AD)
电惊厥疗法加常规护理与模拟 ECT 加常规护理对阿尔茨海默氏痴呆症严重激越急性管理 (ECT-AD) 的随机对照试验
- 批准号:
10224086 - 财政年份:2018
- 资助金额:
$ 17.94万 - 项目类别:
A Randomized Controlled Trial of Electroconvulsive Therapy plus Usual Care versus Simulated-ECT plus Usual Care for the Acute Management of Severe Agitation in Alzheimer's Dementia (ECT-AD)
电惊厥疗法加常规护理与模拟 ECT 加常规护理对阿尔茨海默氏痴呆症严重激越急性管理 (ECT-AD) 的随机对照试验
- 批准号:
9788999 - 财政年份:2018
- 资助金额:
$ 17.94万 - 项目类别:
Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)
屈大麻酚辅助治疗阿尔茨海默病 (AD) 躁动的初步试验
- 批准号:
10170190 - 财政年份:2016
- 资助金额:
$ 17.94万 - 项目类别:
Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)
屈大麻酚辅助治疗阿尔茨海默病 (AD) 躁动的初步试验
- 批准号:
9104639 - 财政年份:2016
- 资助金额:
$ 17.94万 - 项目类别:
Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)
屈大麻酚辅助治疗阿尔茨海默病 (AD) 躁动的初步试验
- 批准号:
9706077 - 财政年份:2016
- 资助金额:
$ 17.94万 - 项目类别:
Effect of Covid-19 on Caregivers of Persons with Dementia
Covid-19 对痴呆症患者照顾者的影响
- 批准号:
10220410 - 财政年份:2016
- 资助金额:
$ 17.94万 - 项目类别:
Cerebral Energy Metabolism in Geriatric Bipolar Depression
老年双相抑郁症的大脑能量代谢
- 批准号:
8016112 - 财政年份:2009
- 资助金额:
$ 17.94万 - 项目类别:
Cerebral Energy Metabolism in Geriatric Bipolar Depression
老年双相抑郁症的大脑能量代谢
- 批准号:
8214530 - 财政年份:2009
- 资助金额:
$ 17.94万 - 项目类别:
Cerebral Energy Metabolism in Geriatric Bipolar Depression
老年双相抑郁症的大脑能量代谢
- 批准号:
7582632 - 财政年份:2009
- 资助金额:
$ 17.94万 - 项目类别:
相似国自然基金
TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
- 批准号:82220108016
- 批准年份:2022
- 资助金额:252 万元
- 项目类别:国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
- 批准号:81800806
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
- 批准号:81700824
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
- 批准号:81670269
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
老年人一体化编码的认知神经机制探索与干预研究:一种减少与老化相关的联结记忆缺陷的新途径
- 批准号:31470998
- 批准年份:2014
- 资助金额:87.0 万元
- 项目类别:面上项目
相似海外基金
A bioluminescent-based imaging probe for noninvasive longitudinal monitoring of CoQ10 uptake in vivo
基于生物发光的成像探针,用于体内 CoQ10 摄取的无创纵向监测
- 批准号:
10829717 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:
Improving sleep and circadian functioning, daytime functioning, and well-being for midlife and older adults by improving patient memory for a transdiagnostic sleep and circadian treatment
通过改善患者对跨诊断睡眠和昼夜节律治疗的记忆,改善中年和老年人的睡眠和昼夜节律功能、日间功能和福祉
- 批准号:
10708424 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:
Cognitive aging in long-term breast cancer survivors
长期乳腺癌幸存者的认知衰老
- 批准号:
10566264 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别:
Extratumoral biological determinants that decrease survival in older adults with glioblastoma
降低老年胶质母细胞瘤患者生存率的肿瘤外生物决定因素
- 批准号:
10741380 - 财政年份:2023
- 资助金额:
$ 17.94万 - 项目类别: